Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...

Merck CEO Robert Davis joins 'Mornings with Maria' to discuss the new $1 billion biologics manufacturing facility slated to ...

It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.

Merck starts construction on a $1B biologics facility in Wilmington, Del., expected to create 500+ jobs and support Keytruda production.

Get an exclusive first look at Wilmington's groundbreaking Think Do Hub library. From rooftop gardens to tech labs, see ...

With $30 million in state grants, pharmaceutical giant Merck is building a factory to employ at least 375 at an old DuPont ...

Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...

Members of the public voiced concerns about cuts to emergency aid and pushed for 1960s-style civil disobedience.

Juanita's Foods, a family-owned Mexican food manufacturer based in Wilmington, has been acquired by private equity firm Apex ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical ...

I've traveled to 80 countries, and I'm always looking for the best restaurants. Whether you're going to Chicago or Dubai, I ...

UD students with visas terminated by the Trump administration without warning this month have seen their records restored, as ...